scholarly journals Efficacy of Influenza Like Illness (ILI) Screening OPD for COVID-19 at a High-Volume Centre: Unlocking Routine OPD

Author(s):  
Bhawna Mattoo ◽  
Radhika Sarda ◽  
Arvind Kumar ◽  
Kaleem Fatima ◽  
Ravneet Kaur ◽  
...  

Abstract Background: The Impact of COVID-19 pandemic over non-essential health services has been massive. We initiated Influenza Like Illness (ILI) screening for resumption of out-patient services at a tertiary care centre and this study attempted to gauge its efficacy in effectively pruning out COVID-19. Methods: We included all the patients who had visited for an OPD appointment during the study period. Patient details and ILI symptoms were noted. Patients were then followed up telephonically after 2 weeks. The telephonic follow up was to ensure RT-PCR status and complaints of any newly developed ILI post OPD visit (within the last 14 days). Results: Out of the 957 patients who were enrolled, 929 patients were successfully followed up telephonically after 14 days. Only 13 who were screened out as ‘possible ILI’, were either RT-PCR negative or did not follow up with a confirmatory test. The telephonic follow up to ensure RT-PCR status and complaints of any newly developed ILI post OPD visit (within the last 14 days) was noted in the rest of the patients. Only 1 participant out of 957 screened, tested positive for COVID-19. Conclusion:The period in which the study was held the national positivity rate was low (around 3%). Therefore, in a resource limited country such as India it is astute to restart the OPD services in the pre-existing setup using basic precautions and a verbal questionnaire during the slope of the pandemic.

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
D Castagno ◽  
M Donadoni ◽  
P.G Golzio ◽  
C Budano ◽  
M Anselmino ◽  
...  

Abstract Introduction Besides the established class I indication for the evaluation of patients with recurrent syncope of uncertain origin, implantable loop recorders (ILRs) have been increasingly used for other diagnostic purposes (e.g. detection of atrial fibrillation (AF) following cryptogenic stroke). Purpose To describe the main indications to ILR and to investigate procedural parameters, outcomes and diagnostic yield of ILR in a single, high-volume tertiary care centre. Methods All patients undergoing ILR implantation between October 2010 and October 2019 were consecutively enrolled in this study. Clinical characteristics of patients, procedural data and outcomes were collected. The indications to ILR implantation were divided into four categories: 1) AF detection in patients with recent cryptogenic stroke or peripheral thromboembolism [CRYSP], 2) recurrent syncope of uncertain origin [RSUO], 3) monitoring of ventricular arrhythmic events [VAE] in patients with predisposing cardiomyopathy/channelopathy, 4) monitoring of AF burden [AFB]. The main endpoint of the study was the diagnostic yield (number of definitive diagnoses made) and the time to diagnosis following ILR implantation. The occurrence of acute or subacute complications was used as a secondary safety endpoint. Results Overall, 1008 patients underwent ILR implantation (mean age 64 years, 43% female). The two main indications to ILR were AF detection following CRYSP and RSUO (41% and 34% of all implantations respectively, table 1). The commonest site of implantation was the left parasternal position (570 patients, 57%), median procedural time was 20 minutes (IQR 15–25). During a median follow-up of 580 days (186–1179), a definitive diagnosis was achieved in 366 (36%) patients after a median time of 208 days (IQR 59–515) [table 1 shows details and action taken following diagnosis for each indication subgroup]. Infections requiring ILR extraction or pocket revision occurred in 12 patients (1.2%). Conclusions In this cohort of patients use of ILR was associated with a good diagnostic yield regardless of the initial indication, triggered timely therapeutic actions and was overall safe. Funding Acknowledgement Type of funding source: None


2013 ◽  
Vol 56 (6) ◽  
pp. 385-392 ◽  
Author(s):  
Elaine Lam ◽  
Scott S. Strugnell ◽  
Chris Bajdik ◽  
Daniel Holmes ◽  
Sam M. Wiseman

2020 ◽  
pp. 1-3
Author(s):  
Richa Sharma ◽  
Ajeet Jain ◽  
Praveen Singh ◽  
Bhushan Shah

STEMI is an event where transmural myocardial ischemia induces myocardial necrosis. PI strategy is a promising strategy in the management of STEMI. It is prospective registry study conducted in Cardiology Department, KGMU between January-June 2016 to know 30 day outcome of thrombolysis alone or thrombolysis followed by PCI in north India.At 30 day follow up, patients undergoing PI strategy,complained less of angina and dyspnea compared to thrombolysis arm.


2021 ◽  
pp. 13-16
Author(s):  
Afthab Jameela Wahab ◽  
Pavithra Gunasekaran ◽  
P. Mohan ◽  
V. Sudha ◽  
L. Balamurugan ◽  
...  

Background - The cutaneous manifestations of the novel coronavirus have been well documented. However, there are few studies that relate to the clinical prole of regular dermatology outpatients seeking treatment during the lockdown relaxation period braving the pandemic. With the Aim - view to determine the changes seen in dermatology outpatient practice, this study analysed the clinical prole of new patients attending the Dermatology Outpatient Department (OPD) during the COVID-19 lockdown relaxation period in a tertiary care centre in a metropolitan suburb in South India. New dermatology outpatients during the months of May, June, July and August Method - 2020 were included in the study. Outpatient data for this period was analysed and compared with corresponding data for the same period in the previous two years. There was a Result – decrease in the OP census, number of patients in the extremes of life as well as those with asymptomatic dermatoses. There was an increase in the number of patients with infections, particularly dermatophytosis. There was also a noteworthy absence of dermatological emergencies. Conclusion - In essence, our study shows the impact of COVID-19 pandemic on the routine dermatology outpatient services with signicant changes in the clinical prole of outpatient practice following lockdown relaxation.


2017 ◽  
Vol 32 (suppl_3) ◽  
pp. iii531-iii531
Author(s):  
S Talwar ◽  
R Nair ◽  
S Sudhindran ◽  
G Kurian ◽  
A Mathew ◽  
...  

2014 ◽  
Vol 66 ◽  
pp. S24
Author(s):  
Kala Jeethender Jain ◽  
Ramesh ◽  
Aditya ◽  
L.S.R. Krishna ◽  
O. Sai Satish

2014 ◽  
Vol 66 ◽  
pp. S105
Author(s):  
P. Vasudeva Chetty ◽  
D. Rajasekhar ◽  
V. Vanajakshamma ◽  
B.S. Praveen kumar ◽  
K.P. Ranganayakulu

2021 ◽  
Vol 8 (2) ◽  
pp. 219
Author(s):  
Archana D. Agrawal ◽  
Gaurav Gupta ◽  
Ashu Bhasin ◽  
Abhishek Singh ◽  
Alpa Rathi

Background: The severe acute respiratory syndrome corona virus-2 (SARS CoV-2) disease pandemic has been a threat to public health and health care system world-wide including routine immunization which has been greatly disrupted putting children at risk for vaccine-preventable diseases (VPDs). A study with an aim to analyse the impact of COVID-19 pandemic on routine immunization coverage post lockdown at a tertiary care centre of western UP.Methods: A retrospective analytical study was conducted at LLRM Medical College, Meerut comparing 3 periods of year 2020, each of 4 weeks viz: 1-28th of February, 1-28 of August and 1-28 of December.Results: Total number of vaccine beneficiaries decreased significantly post lockdown from 646 in February to 275 and 419 in August and December respectively. The percent reduction was maximally seen in booster vaccines while birth dose group was least affected. There was 76.2% and 39.3% reduction in number of children receiving primary doses of combination vaccines in August and December period respectively as compared to February 2020. We found 68.42% and 54.39 % reduction in MR-1 beneficiaries in August and December respectively as compared to February 2020.Conclusions: Significant reduction is found in total number of children receiving immunization during un-lockdown period, compared to pre-COVID level. This difference was more significant in booster doses compared to birth doses. We did not find any significant catch up in vaccine beneficiaries by December 2020 despite 7 months of un-lockdown raising significant concern for public health.


Sign in / Sign up

Export Citation Format

Share Document